The present invention is a chemical compound of formula (I)
1
or a pharmaceutically acceptable salts, solvates and esters thereof, wherein R
1
to R
4
, A
1
, A
2
m and n are as described in the specification.
Compounds of formula (I) and their use as pharmaceutical.
化合物的分子式(I)及其作为药用的用途。
[EN] SUBSTITUTED BENZYLINDAZOLES FOR USE AS BUB1 KINASE INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES.<br/>[FR] BENZYLINDAZOLES SUBSTITUÉS POUR L'UTILISATION EN TANT QU'INHIBITEURS DE BUB1 KINASE DANS LE TRAITEMENT DE MALADIES D'HYPERPROLIFÉRATION
申请人:BAYER PHARMA AG
公开号:WO2013050438A1
公开(公告)日:2013-04-11
Compounds of formula (I) which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals.
式(I)的化合物是Bub1激酶的抑制剂,其生产过程以及它们作为药物的用途。
SUBSTITUTED BENZYLINDAZOLES FOR USE AS BUB1 KINASE INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
申请人:Bayer Intellectual Property GmbH
公开号:US20140249133A1
公开(公告)日:2014-09-04
Compounds of formula (I) which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals.
式(I)的化合物是Bub1激酶的抑制剂,其制备过程及其用作药物的方法。
Substituted benzylpyrazoles
申请人:Bayer Intellectual Property GmbH
公开号:US09260412B2
公开(公告)日:2016-02-16
Compounds of formula (I) and their use as pharmaceutical.